Losartan - Scienture
Alternative Names: Arbli; ArbliTM; Losartan Potassium - Scienture; SCN-102Latest Information Update: 17 Sep 2025
At a glance
- Originator Scienture
- Class Alcohols; Alkanes; Antihypertensives; Biphenyl compounds; Chlorinated hydrocarbons; Heart failure therapies; Imidazoles; Ischaemic heart disorder therapies; Small molecules; Tetrazoles
- Mechanism of Action Angiotensin type 1 receptor antagonists
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
- New Molecular Entity No
Highest Development Phases
- Marketed Diabetic nephropathies; Hypertension
Most Recent Events
- 17 Sep 2025 Chemical structure information added.
- 16 Sep 2025 Launched for Diabetic nephropathies in USA (PO) before September 2025
- 16 Sep 2025 Launched for Hypertension (In children, In adolescents, In adults, In the elderly) in USA (PO) before September 2025